Indian Premas Biotech collabs with American company for development of oral COVID vaccine
Indian Premas Biotech collabs with American company for development of oral COVID vaccine
Share:

Coronavirus vaccine soon to come in a capsule form! Yes, the new forms of corona vaccine are now being developed by several pharma companies across the world. Indian pharma company Premas Biotech has announced the latest is the oral COVID vaccine as a capsule.

Premas Biotech is an Indian firm that is in collab with American company Oramed Pharmaceuticals Inc for the development of an oral vaccine for those candidates who have shown efficacy after a single dose. The first jab of the Oravax corona capsule has been found effective and its efficiency has been proven in a pilot study on animals. The Oravax’s oral vaccine helped by producing Neutralizing Antibodies as well as immune response. Premas Biotech vaccine provides triple protection against three parts of the SARS CoV-2 virus. Dr. Prabuddha Kundu is the co-founder and managing director of Premas'.

 An oral COVID Oravax is a vaccine candidate that controls and combines the true potential as these are preliminary results of animal studies while clinical trials will launch soon in the second quarter of 2021. Another vaccine of Bharat Biotech is also being made in the nasal form along with the University of Wisconsin, which is already undergoing clinical trials. In India, the human stage trials for nasal vaccines have begun.

Also Read:

All schools to remain closed amid rising cases of coronavirus: Yogi Govt

Astronauts For India's Gaganyaan Mission Complete Training in Russia

Smriti Irani Birthday: PM Modi, Amit Shah extend birthday wishes

Join NewsTrack Whatsapp group
Related News